TI
SRRA

Trexquant Investment’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Trexquant Investment’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,131
Closed -$227K – 1966
2022
Q2 		$227K Sell
4,131
-8,013
-66% -$420K 0.01% 1286
2022
Q1 		$389K Buy
+12,144
New +$348K 0.02% 887

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Trexquant Investment's SRRA Position: Q3 2022 in Review

Trexquant Investment sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 4,131 shares — an estimated $227K sold.

Trexquant Investment first reported a position in SRRA in Q1 2022 and held it in 2 quarters. The position peaked at $389K in Q1 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Trexquant Investment reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Trexquant Investment sold 4,131 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $227K.
  • Trexquant Investment first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Trexquant Investment's Sierra Oncology, Inc. Common Stock position peaked at $389K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Trexquant Investment's 13F filing for Q3 2022, filed 14 Nov 2022.